1. Pharmacokinetic and pharmacodynamic drug interactions with kava (Piper methysticum Forst f.);Anke;J. Ethnopharmacol.,2004
2. Kava hepatotoxicity: Are we any closer to the truth?;Anke;Planta Med.,2004
3. Validation of Piper methysticum var Wichmannii (Piperaceae);Applequist;Novon,2006
4. BfArM, 2002. Bundesinstitut für Arzneimittel und Medizinprodukte, Bonn. Federal Institute for Drugs and Medicinal Products in Germany. Rejection of Drug Risks, Step II. As related to: Kava-Kava (Piper methysticum)-containing, and kavain-containing drugs, including homeopathic preparations with a final concentration up to, and including D4. June 14, 2002. Available at: http://www.spc.int/cis/documents/02_0714_BfArM_Kava_Removal.pdf (accessed 20.06.11).
5. Traditional kava beverage consumption and liver function tests in a predominantly Tongan population in Hawaii;Brown;Clin. Toxicol.,2007